Results 161 to 170 of about 22,911 (183)
Some of the next articles are maybe not open access.
Expert Opinion on Pharmacotherapy, 2018
Meropenem-vaborbactam is a new beta-lactam/beta-lactamase inhibitor combination that combines a carbapenem antibiotic with a first-in-class, boronic acid pharmacophore, serine beta-lactamase inhibitor which has potent inhibitory activity against class A carbapenemases, especially Klebsiella pneumoniae carbapenemases (KPC), in addition to other class A ...
Gary, Wu, Eunah, Cheon
openaire +2 more sources
Meropenem-vaborbactam is a new beta-lactam/beta-lactamase inhibitor combination that combines a carbapenem antibiotic with a first-in-class, boronic acid pharmacophore, serine beta-lactamase inhibitor which has potent inhibitory activity against class A carbapenemases, especially Klebsiella pneumoniae carbapenemases (KPC), in addition to other class A ...
Gary, Wu, Eunah, Cheon
openaire +2 more sources
Meropenem/vaborbactam cost effective in Italy
PharmacoEconomics & Outcomes News, 2021openaire +1 more source

